The official journal of the GMA is Public Health Genomics

Public Health Genomics is the leading international journal focusing on the timely translation of genome-based knowledge and technologies into public health, health policies, and healthcare as a whole. This peer-reviewed journal is a bimonthly forum featuring original papers, reviews, short communications, and policy statements.


in scope, it combines theoretical and empirical work from a range of disciplines.

More Details

Impact Factor

With an Impact Factor of 2.12 (2014) it is the leading international journal in the field.

More Details

Topic-specific Issues

provide a comprehensive, holistic and 'all-inclusive' picture of the chosen subject.

More Details

GMA Working Groups

One of the key goals of the Genomic Medicine Alliance is to encourage and catalyze multidisciplinary collaborative research between partner institutions and scientists, particularly from emerging countries and to establish collaboration ties among research organizations, clinical entities and regulatory agencies in areas related to genomic medicine.

Genome Informatics Working Group

The National/Ethnic Mutation Databases are mutation depositories, recording extensive information over the described genetic heterogeneity of an ethnic group or population.

Pharmacogenomics Working Group

We wish to focus on severe drug-induced adverse events, such as Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug-induced liver injury.

Cancer Genomics Working Group

Thanks to the deep-sequencing technologies, the past decade has seen the characterization of nucleic acid alterations in a wide range of cancers generating a large body of information how cancer develops and evolves.

Rare Diseases Working Group

Rare diseases (RD) are more than 7.000; whilst individual conditions can be very infrequent, RD overall affect millions of citizens  at global level, and are considered as a whole a significant issue.

Public Health Genomics Working Group

In the post-genomic era, we are witnessing significant advances in the functional decipherment of the human genome sequence that have been made possible by new technological developments in the field of genomic medicine.

Health Economics Working Group

Economic analysis allows healthcare decision makers to make resource allocation decisions, by performing cost-benefit analysis of the various interventions. Such analyses are important in the area of pharmacogenomics.

Genethics Working Group

The recent advances in the genomic technology and deciphering of the human genome sequence have opened new paths in modern medicine but also posed ethical challenges and dilemmas.

Popular GMA News

Cell Symposium, November 8-10, 2015, Singapore

We would like to bring to your attention the upcoming Cell Symposium: Human Genomics, organized by...

Read More

Contact GMA

Genomic Medicine Alliance

16, Northumberland Αvenue, Craven House, London WC2N 5AP, United Kingdom

Gen in touch

Tel: +44-207-306.91.00,
E-mail: secretariat {AT} goldenhelix (DOT) org

Want to work with us?
Become a Member